Navigation Links
Herpes virus infection drives HIV infection among non-injecting drug users in New York
Date:6/27/2014

HIV and its transmission has long been associated with injecting drug use, where hypodermic syringes are used to administer illicit drugs. Now, a newly reported study by researchers affiliated with New York University's Center for Drug Use and HIV Research (CDUHR) in the journal PLOS ONE, shows that HIV infection among heterosexual non-injecting drug users (no hypodermic syringe is used; drugs are taken orally or nasally) in New York City (NYC) has now surpassed HIV infection among persons who inject drugs.

The study, "HSV-2 Co-Infection as a Driver of HIV Transmission among Heterosexual Non-Injecting Drug Users in New York City," was conducted among drug users entering the Mount Sinai Beth Israel drug treatment programs in NYC. The researchers found that HIV infection among non-injecting drug users doubled over the last two decades, from 7% infected in the late 1990s (n= 785) to 14% (n=1764) currently. During this same time-frame, HIV infection among persons who inject drugs fell to 10%.

The increased efficiency for transmitting HIV occurs even when persons with herpes simplex virus 2 (HSV-2) are between outbreaks, as herpes increases both susceptibility to and transmissibility of HIV. More than half of the non-injecting drug users in the study were infected with HSV-2.

"Heterosexual intercourse is usually not very efficient for transmitting HIV, but the efficiency of heterosexual transmission nearly triples in the presence of herpes simplex virus type 2," notes the study's lead author, Don Des Jarlais, PhD, Deputy Director, Research Methods and Infectious Diseases Cores, Center for Drug Use and HIV Research (CDUHR) and Professor of Psychiatry and of Preventive Medicine at Mount Sinai Beth Israel. "In New York City, we have done an excellent job of reducing HIV among persons who inject drugs and we must now put more efforts into reducing sexual transmission associated with non-injecting drug use."

The study concludes that an increase in HIV infection among these non-injecting drug users is better considered as an increase in HSV- 2/HIV co-infection rather than simply an increase in HIV prevalence. Additional interventions (such as treatment as prevention and pre-exposure prophylaxis) are needed to reduce further HIV transmission from HSV-2/HIV co-infected non-injecting drug users.

The City Department of Health and Mental Hygiene has initiated a program "treatment as prevention," in which HIV infected persons are given anti-viral medications to both protect their own health and to reduce the chances that they will transmit HIV to others. There are also new federal recommendations to provide anti-retroviral medications to HIV uninfected persons at high risk for becoming infected.

"If we can implement these programs on a large scale, we should be able to control sexual transmission of HIV in the city, and achieve the goal of an "End to the AIDS Epidemic," said Dr. Des Jarlais.


'/>"/>

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University
Source:Eurekalert

Related biology news :

1. Herpesviruses undercover
2. Herpes-loaded stem cells used to kill brain tumors
3. New research on inherited herpesvirus may have implications for transplantation
4. Herpes infections: Natural killer cells activate hematopoiesis
5. How herpesvirus invades nervous system
6. Einstein study reveals new approach for stopping herpes infections
7. Novel treatment approach for bladder pain using a herpes simplex virus vector reported
8. Princeton researchers identify unexpected bottleneck in the spread of herpes simplex virus
9. How and why herpes viruses reactivate to cause disease
10. USAMRIID research sheds light on how deadly lassa virus infects cells
11. New infections cause dormant viruses to reactivate
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/9/2016)... Paris Police Prefecture ... solution to ensure the safety of people and operations in ... major tournament Teleste, an international technology group specialised ... today that its video security solution will be utilised by ... public safety across the country. The system roll-out is scheduled ...
(Date:6/2/2016)... June 2, 2016 The Department of ... awarded the 44 million US Dollar project, for the ... Plates including Personalization, Enrolment, and IT Infrastructure , ... the production and implementation of Identity Management Solutions. Numerous renowned ... Decatur was selected for the most ...
(Date:6/1/2016)... 1, 2016 Favorable Government Initiatives ... and Criminal Identification to Boost Global Biometrics System Market ... TechSci Research report, " Global Biometrics Market By ... and Opportunities, 2011 - 2021", the global biometrics market ... on account of growing security concerns across various end ...
Breaking Biology News(10 mins):
(Date:11/30/2016)... NC (PRWEB) , ... November 30, 2016 , ... ... engaged in the development of a new orally administered treatment for Alzheimer’s disease ... neuroimaging results of a Phase 2a clinical trial of T3D-959 in mild to ...
(Date:11/30/2016)... ... November 30, 2016 , ... With growth rates averaging more ... five years and look forward to continuing their expansion in their new office space. ... which has been traditionally favoured by the creative industries, so Random42 Scientific Communication will ...
(Date:11/30/2016)... ... November 30, 2016 , ... ... and groundbreaking venture founded by Arianna Huffington, as part of the Thrive Global ... Gut Explorer Kit, enabling purchasers to explore the microorganisms in their gut, collectively ...
(Date:11/30/2016)... The global  HIV-1 therapeutics market  is expected to reach a value of USD ... new report by Grand View Research, Inc., HIV continues to be one of ... Reading ... Grand View Research Logo ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757) ...
Breaking Biology Technology: